Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 67,234 | 78,637 | 105,762 | 181,564 | 114,634 |
| Receivables | 19,688 | 22,454 | 12,531 | 7,712 | N/A |
| Inventories | 7,214 | 5,065 | 6,702 | 5,512 | 0 |
| Other current assets | 4,373 | 4,955 | 5,452 | 7,473 | 7,729 |
| TOTAL | $98,509 | $111,111 | $130,447 | $202,261 | $122,363 |
| Non-Current Assets | |||||
| PPE Net | 42 | 224 | 604 | 1,847 | 1,825 |
| Intangibles | 2,276 | 2,631 | 2,986 | 1,663 | 0 |
| Other Non-Current Assets | 19,077 | 13,903 | 7,419 | 7,012 | 7,859 |
| TOTAL | $21,395 | $16,758 | $11,009 | $10,522 | $9,684 |
| Total Assets | $119,904 | $127,869 | $141,456 | $212,783 | $132,047 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,662 | 6,060 | 14,175 | 13,552 | 9,372 |
| Accrued Expenses | 16,406 | 13,166 | 13,241 | 12,540 | 8,197 |
| TOTAL | $23,698 | $20,128 | $28,284 | $27,875 | $19,535 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,202 | 6,756 | 3,951 | 4,802 | 6,676 |
| TOTAL | $4,202 | $6,756 | $3,951 | $4,802 | $6,676 |
| Total Liabilities | $27,900 | $26,884 | $32,235 | $32,677 | $26,211 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,218 | 43,777 | 43,678 | 43,714 | 43,526 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -487,136 | -457,470 | -436,043 | -340,475 | -285,200 |
| Other shareholders' equity | 2,264 | 449 | 1,331 | 1,371 | -526 |
| TOTAL | $92,004 | $100,985 | $109,221 | $180,106 | $105,836 |
| Total Liabilities And Equity | $119,904 | $127,869 | $141,456 | $212,783 | $132,047 |